Literature DB >> 4921221

The treatment of sarcoidosis.

H L Israel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4921221      PMCID： PMC2467282          DOI： 10.1136/pgmj.46.538.537

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Course and prognosis of sarcoidosis.

Authors:  M SONES; H L ISRAEL
Journal:  Am J Med       Date:  1960-07       Impact factor: 4.965

2.  Cortisone treatment of sarcoidosis: experience with thirty-six cases.

Authors:  H L ISRAEL; M SONES; D HARRELL
Journal:  J Am Med Assoc       Date:  1954-10-02

3.  Sarcoidosis: clinical features and management.

Authors:  L E Siltzbach
Journal:  Med Clin North Am       Date:  1967-03       Impact factor: 5.456

4.  Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies.

Authors:  O P Sharma; C Colp; M H Williams
Journal:  Am J Med       Date:  1966-10       Impact factor: 4.965

5.  Prolonged treatment of pulmonary sarcoidosis with corticosteroids.

Authors:  C Hoyle; H Smyllie; D Leak
Journal:  Thorax       Date:  1967-11       Impact factor: 9.139
  5 in total
  7 in total

Review 1.  A clinical approach to the use of methotrexate for sarcoidosis.

Authors:  R P Baughman; E E Lower
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Sarcoid of the nervous system.

Authors:  W R Slade
Journal:  J Natl Med Assoc       Date:  1979-12       Impact factor: 1.798

3.  Therapy of sarcoidosis initiated with alternate-day prednisone.

Authors:  J N Sheagren; H B Simon; R R Rich
Journal:  J Natl Med Assoc       Date:  1973-09       Impact factor: 1.798

Review 4.  Primary care paradigm for management of sarcoidosis, Part 1.

Authors:  R C Young; R E Rachal; B Nelson-Knuckles; C N Arthur; H V Nevels
Journal:  J Natl Med Assoc       Date:  1997-03       Impact factor: 1.798

Review 5.  Treatment of Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

6.  When should sarcoidosis be treated?

Authors:  R C Young; R E Rachal; C L Cowan
Journal:  J Natl Med Assoc       Date:  1986-09       Impact factor: 1.798

7.  Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period.

Authors:  Robert P Baughman; Johanna P Cremers; Martina Harmon; Elyse E Lower; Marjolein Drent
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-09-30       Impact factor: 0.670
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.